Catalyst Wire Dossier Catalyst Wire Dossier

Resolute Integrity Zotarolimus-Eluting Coronary Stent System

Zotarolimus-eluting coronary stent system · Medtronic
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Resolute Integrity Zotarolimus-Eluting Coronary Stent System, covering 2015-11-25 to 2016-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY) [Phase 3]

See pricing